Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Foster

Showing results (1181-1190 of 1,276) with videos related to

Pageof 128
Sort By:
Blood Advances|February 27, 2023
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia BAmy D Shapiro, Roshni Kulkarni, Margaret V Ragni, et al.
Journal of Medicinal Chemistry|October 29, 2008
Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic painBrian Dyck, Junko Tamiya, Florence Jovic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 4, 2018
Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader ProteinsGregory C Sartor, Andrea M Malvezzi, Ashok Kumar, et al.
Journal of the American College of Cardiology|May 25, 2010
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialDean J Kereiakes, Louis A Cannon, Robert L Feldman, et al.
Bioorganic & Medicinal Chemistry|June 5, 2007
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activityJoe A Tran, Fabio C Tucci, Wanlong Jiang, et al.
Journal of Medicinal Chemistry|October 9, 2007
Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexiaChen Chen, Wanlong Jiang, Fabio Tucci, et al.
Journal of Neuromuscular Diseases|October 10, 2022
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant CohortTina Duong, Priya S Kishnani, Kristina An Haack, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
Psycho-Oncology|February 5, 2015
Managing fatigue after cancer treatment: development of RESTORE, a web-based resource to support self-managementC Foster, L Calman, C Grimmett, et al.
JAMA|December 29, 2016
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical TrialAndrew L Himelstein, Jared C Foster, James L Khatcheressian, et al.
Pageof 128

Showing results (1181-1190 of 1,276) with videos related to

Sort By:
Pageof 128
Blood Advances|February 27, 2023
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia BAmy D Shapiro, Roshni Kulkarni, Margaret V Ragni, et al.
Journal of Medicinal Chemistry|October 29, 2008
Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic painBrian Dyck, Junko Tamiya, Florence Jovic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 4, 2018
Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader ProteinsGregory C Sartor, Andrea M Malvezzi, Ashok Kumar, et al.
Journal of the American College of Cardiology|May 25, 2010
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialDean J Kereiakes, Louis A Cannon, Robert L Feldman, et al.
Bioorganic & Medicinal Chemistry|June 5, 2007
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activityJoe A Tran, Fabio C Tucci, Wanlong Jiang, et al.
Journal of Medicinal Chemistry|October 9, 2007
Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexiaChen Chen, Wanlong Jiang, Fabio Tucci, et al.
Journal of Neuromuscular Diseases|October 10, 2022
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant CohortTina Duong, Priya S Kishnani, Kristina An Haack, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
Psycho-Oncology|February 5, 2015
Managing fatigue after cancer treatment: development of RESTORE, a web-based resource to support self-managementC Foster, L Calman, C Grimmett, et al.
JAMA|December 29, 2016
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical TrialAndrew L Himelstein, Jared C Foster, James L Khatcheressian, et al.
Pageof 128